Johnson & Johnson Agrees To Pay $700 Million To Settle Charges That It Misled Customers (Photo @JNJNews)
To settle an investigation into American pharmaceutical corporation Johnson and Johnson’s alleged cancer-causing ingredients in its product, the multi-national company has reportedly agreed to pay a whopping 700 million dollars. The were probes by 42 US states and Washington, DC into the allegations that the company misled customers with its marketing advertisement to make them believe that its talc-based products are safe.
The New Jersey-based company was facing over 60,000 sues as of March 31 and counting. Customers were alleging that the company fraudulently concealed the dangers in its baby powder and other talc-based products, allegedly causing cancers.
Most of the complainants are women with ovarian cancer. Several also complained of mesothelioma, a type of cancer linked to asbestos.
It is alleged that that Johnson & Johnson baby powder products contain cancer-causing Asbestos. The ingredient reportedly increases the risk of developing mesothelioma, ovarian cancer, peritoneal cancer, and testicular mesothelioma.
Read also: Explainer: Amid Lawsuits, AstraZeneca Admits Its Covishield Vaccine Causes “Side Effects In Very Rare Cases”
In 2023, the company had stopped selling the alleged cancer-causing products across the world. However, it has not admitted that its baby powder and other products cause cancer, stating that no products the firm contain asbestos. Reiterating that its products do not cause cancer, J&J announced a settlement in January.
Read also: World’s First Rollout Of Cancer Jab That Cuts Treatment Time By Up To 75%
“The company continues to pursue several paths to achieve a comprehensive and final resolution of the talc litigation,” said Erik Haas, J&J worldwide vice president of litigation.
